{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:57:16Z","timestamp":1776142636900,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"National Cancer Institute Division of Cancer Epidemiology and Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijid.2026.108483","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T15:58:36Z","timestamp":1771084716000},"page":"108483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["IFNL4 genotype is associated with hepatitis A virus infection: Findings from a focused phenotype study in the UK Biobank Cohort"],"prefix":"10.1016","volume":"165","author":[{"given":"Neha","family":"Agarwala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minkyo","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc G.","family":"Ghany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aubrey K.","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Engels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludmila","family":"Prokunina-Olsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell J.","family":"Machiela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7791-2698","authenticated-orcid":false,"given":"Ruth M.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijid.2026.108483_bib0001","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.ijid.2026.108483_bib0002","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.ijid.2026.108483_bib0003","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.ijid.2026.108483_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004681","article-title":"Selection on a variant associated with improved viral clearance drives local, adaptive pseudogenization of interferon lambda 4 (IFNL4)","volume":"10","author":"Key","year":"2014","journal-title":"PLoS Genet"},{"issue":"5","key":"10.1016\/j.ijid.2026.108483_bib0005","doi-asserted-by":"crossref","first-page":"106258","DOI":"10.1016\/j.jinf.2024.106258","article-title":"IFNL4 genotype and other personal characteristics to predict response to 8-week sofosbuvir-based treatment for chronic hepatitis C","volume":"89","author":"O\u2019Brien","year":"2024","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.ijid.2026.108483_bib0006","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/infdis\/jit433","article-title":"Association of the IFNL4-\u0394G allele with impaired spontaneous clearance of hepatitis C virus","volume":"209","author":"Aka","year":"2014","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2026.108483_bib0007","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jhep.2015.06.035","article-title":"Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance","volume":"63","author":"O\u2019Brien","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2026.108483_bib0008","series-title":"Abstract #2613-A- 2023 AASLD Annual Liver Meeting.,\u201c Hepatology, Abstract #2613-A- 2023 AASLD Annual Liver Meeting. Abstract #2613-A- 2023 AASLD Annual Liver Meeting","first-page":"S1256","article-title":"Role of IFNL4 genotype in hepatic inflammation among black individuals with chronic hepatitis C","volume":"78","author":"Gopalakrishna","year":"2023"},{"issue":"10","key":"10.1016\/j.ijid.2026.108483_bib0009","doi-asserted-by":"crossref","first-page":"e715","DOI":"10.1016\/S2352-3026(20)30294-5","article-title":"Association of donor IFNL4 genotype and non-relapse mortality after unrelated donor myeloablative haematopoietic stem-cell transplantation for acute leukaemia: a retrospective cohort study","volume":"7","author":"Gadalla","year":"2020","journal-title":"Lancet Haematol"},{"issue":"284","key":"10.1016\/j.ijid.2026.108483_bib0010","doi-asserted-by":"crossref","first-page":"284ra59","DOI":"10.1126\/scitranslmed.aaa4304","article-title":"Interferon-\u03bb restricts West Nile virus neuroinvasion by tightening the blood-brain barrier","volume":"7","author":"Lazear","year":"2015","journal-title":"Sci Transl Med"},{"issue":"11","key":"10.1016\/j.ijid.2026.108483_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003773","article-title":"Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia","volume":"9","author":"Crotta","year":"2013","journal-title":"PLoS Pathog"},{"issue":"13","key":"10.1016\/j.ijid.2026.108483_bib0012","article-title":"IFN-lambda prevents influenza virus spread from the upper airways to the lungs and limits virus transmission","volume":"7","author":"Klinkhammer","year":"2018","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.ijid.2026.108483_bib0013","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2017.04.025","article-title":"Interferon-lambda mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness","volume":"46","author":"Galani","year":"2017","journal-title":"Immunity"},{"issue":"6219","key":"10.1016\/j.ijid.2026.108483_bib0014","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1258100","article-title":"Interferon-lambda cures persistent murine norovirus infection in the absence of adaptive immunity","volume":"347","author":"Nice","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ijid.2026.108483_bib0015","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ni.3180","article-title":"Interferon-\u03bb and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection","volume":"16","author":"Hern\u00e1ndez","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ijid.2026.108483_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101303","article-title":"Type III IFNs: beyond antiviral protection","volume":"43","author":"Kotenko","year":"2019","journal-title":"Semin Immunol"},{"key":"10.1016\/j.ijid.2026.108483_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.764062","article-title":"Type III interferons: emerging roles in autoimmunity","volume":"12","author":"Manivasagam","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.ijid.2026.108483_bib0018","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/gepi.20589","article-title":"The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery","volume":"35","author":"Pendergrass","year":"2011","journal-title":"Genet Epidemiol"},{"issue":"12","key":"10.1016\/j.ijid.2026.108483_bib0019","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nbt.2749","article-title":"Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data","volume":"31","author":"Denny","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"3","key":"10.1016\/j.ijid.2026.108483_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"issue":"7726","key":"10.1016\/j.ijid.2026.108483_bib0021","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2026.108483_bib0022","unstructured":"\"UKBiobank: Clinical coding classification systems and maps.\" UKBiobank. https:\/\/biobank.ndph.ox.ac.uk\/showcase\/refer.cgi?id=592 [accessed 11 February 2024]."},{"issue":"1","key":"10.1016\/j.ijid.2026.108483_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-biodatasci-122320-112352","article-title":"Using Phecodes for research with the electronic health record: from PheWAS to PheRS","volume":"4","author":"Bastarache","year":"2021","journal-title":"Annu Rev Biomed Data Sci"},{"issue":"1","key":"10.1016\/j.ijid.2026.108483_bib0024","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"issue":"2","key":"10.1016\/j.ijid.2026.108483_bib0025","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s10875-022-01376-5","article-title":"Fulminant viral Hepatitis in two siblings with inherited IL-10RB deficiency","volume":"43","author":"Korol","year":"2023","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.ijid.2026.108483_bib0026","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033456","article-title":"Comparative pathology of hepatitis A virus and hepatitis E virus infection","volume":"9","author":"Cullen","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ijid.2026.108483_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2010.03.022","article-title":"Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients","volume":"53","author":"Abe","year":"2010","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.ijid.2026.108483_bib0028","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/hep.24678","article-title":"IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes","volume":"55","author":"Bochud","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ijid.2026.108483_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091822","article-title":"Impact of IL28B genetic variation on HCV-induced liver fibrosis, inflammation, and steatosis: a meta-analysis","volume":"9","author":"Sato","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2026.108483_bib0030","first-page":"912","article-title":"Accuracy and completeness of clinical coding using ICD-10 for ambulatory visits","volume":"2017","author":"Horsky","year":"2017","journal-title":"AMIA Annu Symp Proc"},{"issue":"1","key":"10.1016\/j.ijid.2026.108483_bib0031","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2017.08.034","article-title":"Type A viral hepatitis: a summary and update on the molecular virology, epidemiology, pathogenesis and prevention","volume":"68","author":"Lemon","year":"2018","journal-title":"J Hepatol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226001189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226001189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:24:36Z","timestamp":1776140676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226001189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"alternative-id":["S1201971226001189"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108483","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IFNL4 genotype is associated with hepatitis A virus infection: Findings from a focused phenotype study in the UK Biobank Cohort","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108483"}}